Have a feature idea you'd love to see implemented?
Let us know!
DAWN Day One Biopharmaceuticals Inc
Price (delayed)
$14.47
Market cap
$1.27B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.95
Enterprise value
$1.03B
Highlights
The debt has dropped by 69% year-on-year and by 37% since the previous quarter
The company's EPS rose by 22% QoQ and by 15% YoY
The company's equity fell by 28% YoY but it rose by 3.3% QoQ
The quick ratio has plunged by 78% YoY and by 63% from the previous quarter
Key stats
What are the main financial stats of DAWN
Market
Valuations
Earnings
Shares outstanding
87.76M
Market cap
$1.27B
Enterprise value
$1.03B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.12
Price to sales (P/S)
153.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
125.79
Revenue
$8.19M
EBIT
-$165.93M
EBITDA
-$165.2M
Free cash flow
-$69.37M
Per share
Balance sheet
Liquidity
EPS
-$1.95
Free cash flow per share
-$0.8
Book value per share
$3.51
Revenue per share
$0.09
TBVPS
$4.4
Total assets
$400.44M
Total liabilities
$93.71M
Debt
$190,000
Equity
$306.73M
Working capital
$289.45M
Debt to equity
0
Current ratio
4.09
Quick ratio
3.96
Net debt/EBITDA
1.45
Margins
Efficiency
Dividend
EBITDA margin
-2,016.6%
Gross margin
91.4%
Net margin
-2,044.4%
Operating margin
-3,570.9%
Return on assets
-44.2%
Return on equity
-50%
Return on invested capital
-193.8%
Return on capital employed
-54.1%
Return on sales
-2,025.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
DAWN stock price
How has the Day One Biopharmaceuticals stock price performed over time
Intraday
0.98%
1 week
-4.05%
1 month
0.91%
1 year
39.13%
YTD
-0.89%
QTD
3.88%
Financial performance
How have Day One Biopharmaceuticals's revenue and profit performed over time
Revenue
$8.19M
Gross profit
$7.49M
Operating income
-$292.53M
Net income
-$167.48M
Gross margin
91.4%
Net margin
-2,044.4%
The operating income has plunged by 65% YoY and by 29% from the previous quarter
DAWN's net income is up by 20% since the previous quarter
Growth
What is Day One Biopharmaceuticals's growth rate over time
Valuation
What is Day One Biopharmaceuticals stock price valuation
P/E
N/A
P/B
4.12
P/S
153.89
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
125.79
The company's EPS rose by 22% QoQ and by 15% YoY
The company's equity fell by 28% YoY but it rose by 3.3% QoQ
The stock's P/B is 8% more than its last 4 quarters average of 3.8
Efficiency
How efficient is Day One Biopharmaceuticals business performance
The ROIC has plunged by 186% YoY and by 23% from the previous quarter
The ROA is up by 17% since the previous quarter
Day One Biopharmaceuticals's ROE has increased by 13% from the previous quarter but it has decreased by 7% YoY
Dividends
What is DAWN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for DAWN.
Financial health
How did Day One Biopharmaceuticals financials performed over time
Day One Biopharmaceuticals's current ratio has shrunk by 78% YoY and by 63% QoQ
The quick ratio has plunged by 78% YoY and by 63% from the previous quarter
The debt is 100% smaller than the equity
The debt has dropped by 69% year-on-year and by 37% since the previous quarter
The company's equity fell by 28% YoY but it rose by 3.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.